STOCK TITAN

[Form 4] NEOGEN CORP Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Insider stock activity at NEOGEN (NEOG): Former CEO and officer John Edward Adent had 32,936 restricted stock units vest on 10/07/2025, which were settled into 32,936 shares of common stock at an effective price of $5.63 per share. On the same date, 9,297 shares were disposed of at $5.63, leaving 330,651 shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 10/09/2025.

Attività azionaria degli insider presso NEOGEN (NEOG): l'ex amministratore delegato e dirigente John Edward Adent aveva 32.936 unità di azioni restritte che maturano il 10/07/2025, diventando 32.936 azioni ordinarie a un prezzo effettivo di $5.63 per azione. Nello stesso giorno, 9.297 azioni sono state liquidate a $5.63, lasciando 330.651 azioni detenute beneficiariamente dopo le operazioni. Il documento è stato firmato da un procuratore incaricato il 10/09/2025.

Actividad de insider en NEOGEN (NEOG): El ex CEO y directivo John Edward Adent tenía 32,936 unidades de acciones restringidas que vencen el 10/07/2025, las cuales se convirtieron en 32,936 acciones ordinarias a un precio efectivo de $5.63 por acción. En la misma fecha, 9,297 acciones se liquidaron a $5.63, dejando 330,651 acciones en propiedad beneficiaria tras las transacciones. La presentación fue firmada por un representante con poder el 10/09/2025.

NEOGEN(NEOG) 내부자 주식 활동: 전 CEO 겸 임원 John Edward Adent32,936 주의 제한 주식이 2025/10/07에 취득 시점에 귀속되었고, 이는 32,936 주의 보통주로 실제가 $5.63의 가격으로 전환되었습니다. 같은 날짜에 9,297 주가 $5.63로 처분되어 거래 후 보유 이익 주식이 330,651 주 남았습니다. 이 서류는 2025/10/09에 위임된 변호인이 서명했습니다.

Activité d’initié chez NEOGEN (NEOG) : L’ancien PDG et dirigeant John Edward Adent détenait 32 936 unités d’actions restreintes qui se sont acquises le 10/07/2025, et ont été converties en 32 936 actions ordinaires à un prix effectif de $5,63 par action. À la même date, 9 297 actions ont été cédées à $5,63, laissant 330 651 actions détenues de manière bénéficiaire après les transactions. Le dépôt a été signé par un mandataire le 10/09/2025.

Insider-Aktienaktivität bei NEOGEN (NEOG): Der ehemalige CEO und Vorstandsmitglied John Edward Adent hatte 32.936 Restricted Stock Units, die am 10/07/2025 vesteten und in 32.936 Stammaktien zu einem effektiven Preis von $5.63 pro Aktie umgewandelt wurden. Am selben Datum wurden 9.297 Aktien zu $5.63 veräußert, wodurch nach den Transaktionen 330.651 Aktien vorteilhaft gehalten wurden. Die Einreichung wurde von einem Bevollmächtigten am 10/09/2025 unterschrieben.

نشاط الأسهم للمطلعين في NEOGEN (NEOG): كان لدى الرئيس التنفيذي السابق والموظف John Edward Adent 32,936 وحدة أسهم مقيدةvest في 10/07/2025، والتي تم تسويتها إلى 32,936 سهمًا من الأسهم العادية بسعر فعال قدره $5.63 للسهم. في نفس التاريخ، تم التخلص من 9,297 سهمًا بسعر $5.63 للسهم، مما ترك 330,651 سهمًا مملوكًا فائدةً بعد الصفقات. تم توقيع الملف من قبل وكيلٍ قانونيٍ بالخطة في 10/09/2025.

NEOGEN(NEOG) 内部人交易:前 CEO 及高级职员 John Edward Adent10/07/2025 行使了 32,936 股受限股票单位(RSU),这些将以每股实际价格 $5.63 转化为 32,936 股普通股。同日,9,297 股以 $5.63 的价格出售,交易完成后实际持有的股份为 330,651 股。该申报由代理人于 10/09/2025 签署。

Positive
  • 32,936 RSUs vested, increasing direct share ownership and aligning compensation with equity holders
  • Beneficial ownership remains substantial at 330,651 shares after the transaction
Negative
  • 9,297 shares disposed on the same date, indicating a notable sale that may be for tax or diversification

Insights

Vesting and a small sale occurred; likely routine compensation settlement and tax-related disposition.

The reporting person received 32,936 shares via RSU vesting on 10/07/2025, with each unit settled at $5.63. Such settlements convert deferred compensation into common stock and increase direct ownership.

This filing also shows a contemporaneous disposal of 9,297 shares at the same $5.63 price, which commonly reflects tax-withholding or partial sale to cover obligations. Monitor future Form 4 filings for larger sales or patterned disposals over the next 12 months.

Attività azionaria degli insider presso NEOGEN (NEOG): l'ex amministratore delegato e dirigente John Edward Adent aveva 32.936 unità di azioni restritte che maturano il 10/07/2025, diventando 32.936 azioni ordinarie a un prezzo effettivo di $5.63 per azione. Nello stesso giorno, 9.297 azioni sono state liquidate a $5.63, lasciando 330.651 azioni detenute beneficiariamente dopo le operazioni. Il documento è stato firmato da un procuratore incaricato il 10/09/2025.

Actividad de insider en NEOGEN (NEOG): El ex CEO y directivo John Edward Adent tenía 32,936 unidades de acciones restringidas que vencen el 10/07/2025, las cuales se convirtieron en 32,936 acciones ordinarias a un precio efectivo de $5.63 por acción. En la misma fecha, 9,297 acciones se liquidaron a $5.63, dejando 330,651 acciones en propiedad beneficiaria tras las transacciones. La presentación fue firmada por un representante con poder el 10/09/2025.

NEOGEN(NEOG) 내부자 주식 활동: 전 CEO 겸 임원 John Edward Adent32,936 주의 제한 주식이 2025/10/07에 취득 시점에 귀속되었고, 이는 32,936 주의 보통주로 실제가 $5.63의 가격으로 전환되었습니다. 같은 날짜에 9,297 주가 $5.63로 처분되어 거래 후 보유 이익 주식이 330,651 주 남았습니다. 이 서류는 2025/10/09에 위임된 변호인이 서명했습니다.

Activité d’initié chez NEOGEN (NEOG) : L’ancien PDG et dirigeant John Edward Adent détenait 32 936 unités d’actions restreintes qui se sont acquises le 10/07/2025, et ont été converties en 32 936 actions ordinaires à un prix effectif de $5,63 par action. À la même date, 9 297 actions ont été cédées à $5,63, laissant 330 651 actions détenues de manière bénéficiaire après les transactions. Le dépôt a été signé par un mandataire le 10/09/2025.

Insider-Aktienaktivität bei NEOGEN (NEOG): Der ehemalige CEO und Vorstandsmitglied John Edward Adent hatte 32.936 Restricted Stock Units, die am 10/07/2025 vesteten und in 32.936 Stammaktien zu einem effektiven Preis von $5.63 pro Aktie umgewandelt wurden. Am selben Datum wurden 9.297 Aktien zu $5.63 veräußert, wodurch nach den Transaktionen 330.651 Aktien vorteilhaft gehalten wurden. Die Einreichung wurde von einem Bevollmächtigten am 10/09/2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ADENT JOHN EDWARD

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Former CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/07/2025 M 32,936 A $5.63 339,948 D
Common Stock 10/07/2025 F 9,297 D $5.63 330,651 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.63 10/07/2025 M 32,936 10/07/2025 10/07/2025 Common Stock 32,936 $5.63 0 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG insider John Edward Adent report on Form 4 (NEOG)?

He reported 32,936 RSUs vested and settled into 32,936 shares on 10/07/2025, with 9,297 shares disposed at $5.63.

How many NEOG shares did Adent own after the reported transactions?

He beneficially owned 330,651 shares following the transactions reported on 10/07/2025.

At what price were the RSUs settled and the shares sold?

Both the RSU settlement and the disposed shares show an effective price of $5.63 per share.

When did the RSUs vest and when was the Form 4 signed?

The RSUs vested on 10/07/2025, and the Form 4 was signed by an attorney-in-fact on 10/09/2025.

Does the filing indicate the reason for the share disposal?

The filing states the RSUs vested and were settled; it does not specify the reason for the 9,297 share disposal (common reasons include tax withholding or partial sale).
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.47B
215.23M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING